Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research – Diabetes and Obesity

Volume 2

eBook: US $79 Special Offer (PDF + Printed Copy): US $158
Printed Copy: US $119
Library License: US $316
ISSN: 2467-9607 (Print)
ISSN: 2352-3220 (Online)
ISBN: 978-1-68108-186-1 (Print)
ISBN: 978-1-68108-185-4 (Online)
Year of Publication: 2017
DOI: 10.2174/97816810818541160201

Introduction

Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.

The second volume of this series features 7 reviews presenting updates on hormones and several classes of drugs:

  • - Osteocalcin action in glucose metabolism
  • - Sodium-glucose co-transporter 2 (SGLT2) inhibitors
  • - Glucagon-like peptide-1 (GLP-1) mimetics
  • - Dipeptidyl peptidase 4 (DPP-4) inhibitors
  • - New drugs in clinical trial and commercial phases

Contributors

Editor(s):
Prof. Dr. Atta-ur-Rahman
Kings College
University of Cambridge
Cambridge
UK




Contributor(s):
Angelos A. Evangelopoulos
Roche Hellas Diagnostics
Αthens
Greece


Athanasia K. Papazafiropoulou
1st Department of Internal Medicine & Diabetes Center General Hospital of Piraeus "Tzaneio"
Greece


Christos E. Kazazis
Leicester University
London
UK


Gabriella Lengyel
2nd Department of Internal Medicine, Medical Faculty
Semmelweis University
Budapest
Hungary


Hidesuke Kaji
Division of Physiology and Metabolism
University of Hyogo
Akashi, Hyogo
Japan


Ippei Kanazawa
Department of Internal Medicine 1
Shimane University Faculty of Medicine
Shimane
Japan


Krishnan M. Prasanna Kumar
Center for Diabetes and Endocrine Care
Banglore
India


Marina S. Kardara
Health Center of Erymantheia
Achaia
Greece


Minglong Li
Department of Endocrinology
Provincial Hospital affiliated to Shandong University
Jinan, China


Natalia. G Vallianou
Evangelismos General Hospital Athens
Greece


Shivaprasad Channabasappa
Department of Endocrinology and Metabolism
Vydehi Institute of Medical Sciences & Research Centre
Banglore, India


Tatjana Ábel
Outpatient Department
Military Hospital
Budapest
Hungary
/
Faculty of Health Sciences
Semmelweis University
Budapest
Hungary


Xianglan Sun
Department of Endocrinology
Provincial Hospital affiliated to Shandong University
Jinan
China


Yao Wang
Shandong Institute of Endocrine and Metabolic Diseases
Shandong Academy of Medical Sciences
Jinan, 250062 Shandong
China




RELATED BOOKS

.Phytotherapy in the Management of Diabetes and Hypertension.
.Phytotherapy in the Management of Diabetes and Hypertension.
.Frontiers in Clinical Drug Research – Diabetes and Obesity.
.Understanding Obesity: From its Causes to Impact on Life.